Navigation Links
Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts
Date:8/1/2011

NEW YORK, Aug. 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts

http://www.reportlinker.com/p0581176/Dry-Powder-Inhalation-Devices-Drugs-Therapeutics-Markets-and-Forecasts .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Much of the interest in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions – aliments that require frequent drug administration for a protracted period of time. While several approaches for delivering active substances to, and systematically via, the lungs compete in this space, recent advances and investment in powder formulations, particle engineering, and device architecture have positioned dry powder inhalation (DPI) as a formidable challenger to more established pulmonary methods such as metered dose inhalers and nebulizers. While evolving DPI technology and combination therapeutic products continue to have a significant impact on the treatment of upper respiratory diseases and conditions, dry powder inhalers are making strides in applications requiring the systemic delivery of both small and large molecule and engineered macromolecules for the treatment of a range of pathologies.

Highlights

• Analyzes and evaluates Dry Powder Inhalers and competing inhaled drug delivery technologies and assesses the market potential for existing and probable future products

• Examines Dry Powder Inhaler design issues and evolving market factors

• Forecasts the impact of DPI technology and devices on drug delivery markets and projects probable future developments

• Provides forecasts of DPI combination product demand by indication and drug class to 2014

• Profiles Dry Powder Inhalation market participants, their technology, product development activity, and business strategies

Executive Summary

The Market Picture for Inhaled Therapeutics

Devices, Formulations and Market Evolution

Established Therapeutic Targets

Emerging Therapies

Demographics and Growth

Competing Technologies

Market Drivers

Risk Factors

Dry Powder Inhalation Technology

Dry Powder Formulations

Dry Powder Particle Technology & Powder Engineering

Dry Powder Formulations

Dry Powder Processing

Dry Powder Packaging

Emerging Formulations

Dry Powder Inhalers

DPI Device Characteristics

DPI Design Parameters

DPI Device Assessments

Acu-Breathe (Respirics)

Aerolizer Novartis)

AIR (Civitas/Alkermes)

Airmax (Teva)

Aspirair (Vectura)

Axahaler (S.M.B.)

Breezhaler (Novartis)

Clickhaler (Vectura)

Conix Dry (3M)

Cricket (Mannkind)

Cyclohaler (Teva)

Diskhaler (GlaxoSmithKline)

Diskus (GlaxoSmithKline)

Dreamboat (Mannkind)

Easyhaler (Orion)

EZ Aer (Aerovance)

Flexhaler (AstraZeneca)

Genuair (Almirall)

Gemini (GSK)

Handihaler Boehringer Ingelheim)

MicroDose (MicroDose Therapeutx)

Next DPI (Chiesi)

Novolizer (Meda)

Oximax (Mantecorp)

Podhaler (Novartis)

Pulmojet (sanofi-aventis)

Pulvinal (Chiesi)

Skyehaler (SKyepharma)

Solis (Sandoz/Novartis)

Taifun (Akela)

Taper Dry (3M)

Trivair (Trimel Bipharma)

Twincaps/Flowcaps (Hovione)

Twisthaler (Schering /Merck)

Turbuhaler (AstraZeneca)

Dry Powder Inhalation – Therapeutic Segment Analysis & Forecasts

Upper Respiratory Indications

Disease Segments

Therapeutic Landscape

Prescribing Trends and Growth Factors

Systemic Drug Delivery

Bioterror

Diabetes

Hereditary Diseases

Cystic Fibrosis

Infectious Diseases

Osteoporosis

Neurology

Pain Management

Market Factors

Device Design

Regulatory Issues

Patient Compliance

The Role of CMOs/CSOs

Healthcare Economics

Company Profiles

To order this report:

Drug Delivery Technology Industry: Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts

Drug Delivery Technology Business News

More  Company Profile, SWOT and Revenue Analysis!

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Data Show Aerovances Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients
3. ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
4. New Powder Speeds Healing of Difficult Foot Wounds
5. Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lees Pharmaceuticals
6. FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
7. Hoviones TwinCaps(R) Dry-powder Inhaler Approved in Japan as Part of Inavir(R) Influenza Treatment
8. FDA Approves Pharmaxis ARIDOLâ„¢ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
9. Reportlinker Adds Dry Powder Inhalation
10. Pharmaxis Launches ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
11. RSB Spine, LLC, Announces Distribution Agreement with Paradigm BioDevices, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... India , December 7, 2016 According to ... (Services, Software), Delivery Mode, Product Type (Integrated, Standalone), Model (Knowledge-Based), Type (Therapeutic, ... MarketsandMarkets, The CDSS Market is expected to reach USD 1,519.2 Million by ... Continue Reading ... ...
(Date:12/7/2016)... , Dec. 7,2016  Based on ... delivery industry, Frost & Sullivan recognizes Nemaura ... & Sullivan Award for Enabling Technology Leadership. ... the loopholes in traditional drug delivery technologies, ... liquid microneedle-based drug delivery technologies, Memspatch and ...
(Date:12/7/2016)... Inc. (NASDAQ: IONS ), the leader in antisense therapeutics, ... BMO Capital Markets Prescriptions for Success Healthcare Conference on Wednesday, December ... A live webcast of the presentation will be available on the ... be available within 48 hours and will be archived for a ... , , ...
Breaking Medicine Technology:
(Date:12/7/2016)... Ill. (PRWEB) , ... December 07, 2016 , ... Levels ... early-stage brain damage, according to a study appearing online in the journal Radiology. , ... is expected to increase significantly due to the rapidly aging population. Damage to both ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... is now promoting to the US market its advanced highly customizable contact technology ... and ODU TURNTAC®. These advanced technologies are ideal for a wide range of ...
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... offering insurance and financial planning services to families and business owners in the ... funds on behalf of the Dallas Fallen Officer Foundation. , Established in 2009 ...
(Date:12/7/2016)... ... , ... A. Kevin Spann Insurance, a New York-based firm offering insurance and ... a charity drive to raise funds that will benefit the Marine Corps League. , ... Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... to announce that its fully redesigned website, which launched October 17, 2016, features ... sleek responsive design and easy-to-navigate layout. Visitors and patients can discover the latest ...
Breaking Medicine News(10 mins):